Türk Medline
ADR Yönetimi
ADR Yönetimi

IN SITU NORMOTHERMIC REGIONAL PERFUSION FOR LIVER DONATION FROM CHINA CATEGORY III (ORGAN DONATION AFTER BRAIN DEATH FOLLOWED BY CIRCULATORY DEATH): A SINGLE-CENTER COHORT STUDY

GUANG-YU DİNG, YUN ZHAO, WEİ WU, MİNG ZHONG, PEİ-YAO FU, MİNG XU, JİAN ZHOU, JİA FAN, XİAO-WU HUANG, KANG SONG

Experimental and Clinical Transplantation - 2020;18(1):83-88

From the Department of Liver Surgery and Transplantation, Liver Cancer Institute, Zhongshan Hospital, Fudan University, Key Laboratory of Carcinogenesis and Cancer Invasion of Ministry of Education, Shanghai, China

 

Objectives: Organ donation after brain death followed by circulatory death is practiced in China. This study evaluated the application of normothermic regional perfusion to protect the liver grafts from these donors from warm ischemia in a large transplant center in China. Materials and Methods:This prospective study involved 19 liver transplants from brain death followed by circulatory death donors that were conducted between December 2014 and June 2017. We evaluated the baseline characteristics of the donors and recipients and compared outcomes of both groups. Graft and recipient survival and postoperative complications were also analyzed. Results:Although the normothermic regional perfusion group consisted of marginal donors with prolonged warm ischemia and recipients with higher Model for End-Stage Liver Disease scores (P < .05), postoperative tests indicated no differences in liver function recovery in both groups. Furthermore, total bilirubin decreased significantly faster in the normothermic regional perfusion group than in the control group (P< .05). Both groups showed similar 1-year recipient survival rates. No recipients in the normothermic regional perfusion group had any biliary complications, whereas 2 recipients in the control group developed ischemic cholangiopathy and received invasive treatment during follow-up. Conclusions: In situ normothermic regional perfusion demonstrated a significant benefit in grafts from brain death followed by circulatory death donors and could potentially increase both the number and quality of donated organs.